RE 201;[1,1'-BIPHENYL]-2-SULFONAMIDE, 4'-[(2-BUTYL-4-OXO-1,3-DIAZASPIRO[4.4]NON-1-EN-3-YL)METHYL]-N-(4,5-DIMETHYL-3-ISOXAZOLYL...;2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide;4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2-(ethoxymethyl) [1,1-biphenyl]-2-sulfonamide;Sparsentan(RE-021);Sparsentan-D5(RE-021-D5);BMS-346567;DARA-a;PS433540;RE-021;Sparsentan